Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOMEOPATH COVID-19 early outpatient eradication study
2021-000492-36Phase 2Completed
- Sponsor
- UCLouvain
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of carbocisteine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by UCLouvain. Primary endpoint: Virologic response at Day 6. Started Apr 2021; status: completed.
02
Drugs
carbocisteine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-000492-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000492-36.